October 5, 2026
Uncategorized

Lupin gets US FDA nod for its first biosimilar drug Pegfilgrastim (Soban News)

The product, a biosimilar to Amgen’s popular drug Neulasta, will be manufactured at Lupin’s biotech facility in Pune​The product, a biosimilar to Amgen’s popular drug Neulasta, will be manufactured at Lupin’s biotech facility in Pune ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Big business groups’ diversification game amid slowing growth, rising risks (Soban News)

News-Soban-Admin

Lovable, a Start-Up That Makes Anyone a Coder, Raises $330 Million (Soban News)

News-Soban-Admin

Mutual funds pour ₹8,752 cr in IPOs in Q2 FY26; small-cap bets stay strong (Soban News)

News-Soban-Admin

Leave a Comment